Wednesday, November 30, 2022: M&A

Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of...

Tuesday, November 29, 2022: M&A

AstraZeneca PLC announced it will acquire Neogene Therapeutics Inc. in a deal worth up to $320 million, growing the company’s oncology portfolio. The transaction is expected to close in the first quarter of 2023, subject to customary closing conditions and...

Tuesday, November 29, 2022: M&A

Boston Scientific announced it entered a definitive agreement to acquire Apollo Endosurgery for a cash price of $10 per share to reflect an enterprise value of approximately $615 million. Apollo Endosurgery anticipates net sales of approximately $76 million in the...

Monday, November 21, 2022: M&A

The Department of Justice (DOJ) and two states – New York and Minnesota – issued a notice to appeal a judge’s decision to dismiss their antitrust challenge of UnitedHealth’s acquisition of Change Healthcare. The DOJ sued to block the deal in February,...

Monday, November 21, 2022: M&A

Merck & Co. agreed to acquire cancer developer Imago BioSciences Inc. in a deal valued at $1.35 billion. The deal will add new revenue streams as Merck’s patent deal for cancer treatment Keytruda is set to expire early next year and grow its presence in the...

Wednesday, November 16, 2022: M&A

South Dakota-based Sanford Health and Minnesota-based Fairview Health Services unveiled plans Tuesday to merge and form $14 billion health system serving rural and urban patients across the Midwest. The merger would give Sanford Health access to a major metropolitan...